ReP USP - Resultado da busca

Artigo de periodico
SETDB1 as a cancer target: challenges and perspectives in drug design (2024)
Hassanie, Haifa ; Penteado, André Berndt ; Almeida, Larissa Costa de ; Calil, Raisa Ludmila; Emery, Flavio da Silva ; Costa-Lotufo, Letícia Veras ; Trossini, Gustavo Henrique Goulart
Source: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF
Subjects: NEOPLASIAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 15 out. 2024.
APA
Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
NLM
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Vancouver
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Artigo de periodico
Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products (2024)
Lourenço, Felipe Rebello ; Silva, Ricardo Jorge Neves Bettencourt da
Source: Journal of AOAC International. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOURENÇO, Felipe Rebello e SILVA, Ricardo Jorge Neves Bettencourt da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products. Journal of AOAC International, 2024Tradução . . Disponível em: https://dx.doi.org/10.1093/jaoacint/qsae044. Acesso em: 15 out. 2024.
APA
Lourenço, F. R., & Silva, R. J. N. B. da. (2024). Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products. Journal of AOAC International. doi:10.1093/jaoacint/qsae044
NLM
Lourenço FR, Silva RJNB da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products [Internet]. Journal of AOAC International. 2024 ;[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1093/jaoacint/qsae044
Vancouver
Lourenço FR, Silva RJNB da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products [Internet]. Journal of AOAC International. 2024 ;[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1093/jaoacint/qsae044
Artigo de periodico
PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase (2024)
Obreque, Karin Mariana Torres ; Kleingesinds, Eduardo Krebs ; Santos, João Henrique Picado Madalena ; Carretero, Gustavo Penteado Battesini ; Cunha, Jheniffer Rabelo ; Converti, Attilio ; Monteiro, Gisele ; Pessoa Junior, Adalberto ; Rangel-Yagui, Carlota de Oliveira
Source: Preparative Biochemistry & Biotechnology. Unidade: FCF
Subjects: TERMODINÂMICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OBREQUE, Karin Mariana Torres et al. PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase. Preparative Biochemistry & Biotechnology, v. 54, n. 4, p. 503-513, 2024Tradução . . Disponível em: https://doi.org/10.1080/10826068.2023.2249100. Acesso em: 15 out. 2024.
APA
Obreque, K. M. T., Kleingesinds, E. K., Santos, J. H. P. M., Carretero, G. P. B., Cunha, J. R., Converti, A., et al. (2024). PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase. Preparative Biochemistry & Biotechnology, 54( 4), 503-513. doi:10.1080/10826068.2023.2249100
NLM
Obreque KMT, Kleingesinds EK, Santos JHPM, Carretero GPB, Cunha JR, Converti A, Monteiro G, Pessoa Junior A, Rangel-Yagui C de O. PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase [Internet]. Preparative Biochemistry & Biotechnology. 2024 ; 54( 4): 503-513.[citado 2024 out. 15 ] Available from: https://doi.org/10.1080/10826068.2023.2249100
Vancouver
Obreque KMT, Kleingesinds EK, Santos JHPM, Carretero GPB, Cunha JR, Converti A, Monteiro G, Pessoa Junior A, Rangel-Yagui C de O. PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase [Internet]. Preparative Biochemistry & Biotechnology. 2024 ; 54( 4): 503-513.[citado 2024 out. 15 ] Available from: https://doi.org/10.1080/10826068.2023.2249100
Artigo de periodico
Quality assessment of medicines based on consumer’s and producer’s risk estimation (2023)
Caffaro, Arthur Massabki; Lourenço, Felipe Rebello
Source: Peer Review. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAFFARO, Arthur Massabki e LOURENÇO, Felipe Rebello. Quality assessment of medicines based on consumer’s and producer’s risk estimation. Peer Review, v. 5, p. 322-330, 2023Tradução . . Disponível em: https://dx.doi.org/10.53660/1196.prw2708. Acesso em: 15 out. 2024.
APA
Caffaro, A. M., & Lourenço, F. R. (2023). Quality assessment of medicines based on consumer’s and producer’s risk estimation. Peer Review, 5, 322-330. doi:10.53660/1196.prw2708
NLM
Caffaro AM, Lourenço FR. Quality assessment of medicines based on consumer’s and producer’s risk estimation [Internet]. Peer Review. 2023 ; 5 322-330.[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.53660/1196.prw2708
Vancouver
Caffaro AM, Lourenço FR. Quality assessment of medicines based on consumer’s and producer’s risk estimation [Internet]. Peer Review. 2023 ; 5 322-330.[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.53660/1196.prw2708
Artigo de periodico
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets (2023)
Souza, Mariana Laureano de ; Lapierre, thibault Joseph William Jacques Dit ; Marques, Gabriel Vitor de Lima; Ferraz, Witor Ribeiro ; Penteado, André Berndt ; Trossini, Gustavo Henrique Goulart ; Murta, Silvane Maria Fonseca; Oliveira, Renata Barbosa de; Rezende Junior, Celso de Oliveira ; Ferreira, Rafaela Salgado
Source: Expert Opinion on Therapeutic Targets. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Mariana Laureano de et al. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets. Expert Opinion on Therapeutic Targets, v. 27, p. 911-925, 2023Tradução . . Disponível em: https://dx.doi.org/10.1080/14728222.2023.2264512. Acesso em: 15 out. 2024.
APA
Souza, M. L. de, Lapierre, thibault J. W. J. D., Marques, G. V. de L., Ferraz, W. R., Penteado, A. B., Trossini, G. H. G., et al. (2023). Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets. Expert Opinion on Therapeutic Targets, 27, 911-925. doi:10.1080/14728222.2023.2264512
NLM
Souza ML de, Lapierre thibault JWJD, Marques GV de L, Ferraz WR, Penteado AB, Trossini GHG, Murta SMF, Oliveira RB de, Rezende Junior C de O, Ferreira RS. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets [Internet]. Expert Opinion on Therapeutic Targets. 2023 ; 27 911-925.[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1080/14728222.2023.2264512
Vancouver
Souza ML de, Lapierre thibault JWJD, Marques GV de L, Ferraz WR, Penteado AB, Trossini GHG, Murta SMF, Oliveira RB de, Rezende Junior C de O, Ferreira RS. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets [Internet]. Expert Opinion on Therapeutic Targets. 2023 ; 27 911-925.[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1080/14728222.2023.2264512
Artigo de periodico
Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII (2023)
Greco, Gabriel Luis Cardoso; Segretti, Natanael; Zapatero, Celerino Abad ; Movahedzadehc, Farahnaz; Hirata, Mario Hiroyuki ; Ferreira, Elizabeth Igne ; Ferreira, Glaucio Monteiro
Source: Journal of Biomolecular Structure and Dynamics. Unidade: FCF
Subjects: TUBERCULOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRECO, Gabriel Luis Cardoso et al. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics, 2023Tradução . . Disponível em: https://dx.doi.org/10.1080/07391102.2023.2270528. Acesso em: 15 out. 2024.
APA
Greco, G. L. C., Segretti, N., Zapatero, C. A., Movahedzadehc, F., Hirata, M. H., Ferreira, E. I., & Ferreira, G. M. (2023). Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2023.2270528
NLM
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Vancouver
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 out. 15 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Artigo de periodico
Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space (2023)
Santos, Everton Miranda dos; Ferraz, Humberto Gomes ; Issa, Michele Georges ; Duque, Marcelo Dutra
Source: Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: MEDICAMENTO, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Everton Miranda dos et al. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, v. 112, n. 12, p. 3131-3140, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2023.07.012. Acesso em: 15 out. 2024.
APA
Santos, E. M. dos, Ferraz, H. G., Issa, M. G., & Duque, M. D. (2023). Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, 112( 12), 3131-3140. doi:10.1016/j.xphs.2023.07.012
NLM
Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012
Vancouver
Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012
Parte de monografia/livro
Enzymes as drugs and medicines (2022)
Rangel-Yagui, Carlota de Oliveira ; Vitolo, Michele
Source: Pharmaceutical biotechnology: a focus on industrial application. Unidade: FCF
Subjects: ENZIMAS, MEDICAMENTO, BIOTECNOLOGIA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RANGEL-YAGUI, Carlota de Oliveira e VITOLO, Michele. Enzymes as drugs and medicines. Pharmaceutical biotechnology: a focus on industrial application. Tradução . Boca Raton: CRC Press, 2022. . . Acesso em: 15 out. 2024.
APA
Rangel-Yagui, C. de O., & Vitolo, M. (2022). Enzymes as drugs and medicines. In Pharmaceutical biotechnology: a focus on industrial application. Boca Raton: CRC Press.
NLM
Rangel-Yagui C de O, Vitolo M. Enzymes as drugs and medicines. In: Pharmaceutical biotechnology: a focus on industrial application. Boca Raton: CRC Press; 2022. [citado 2024 out. 15 ]
Vancouver
Rangel-Yagui C de O, Vitolo M. Enzymes as drugs and medicines. In: Pharmaceutical biotechnology: a focus on industrial application. Boca Raton: CRC Press; 2022. [citado 2024 out. 15 ]
Artigo de periodico
Medications adverse effects on voice: comparison between different sources of information (2022)
Cardoso, Leonardo da Rocha; Zenari, Marcia Simões ; Aguiar, Patrícia Melo ; Nemr, Katia
Source: Journal of Voice. Unidades: FM, FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Leonardo da Rocha et al. Medications adverse effects on voice: comparison between different sources of information. Journal of Voice, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jvoice.2022.12.005. Acesso em: 15 out. 2024.
APA
Cardoso, L. da R., Zenari, M. S., Aguiar, P. M., & Nemr, K. (2022). Medications adverse effects on voice: comparison between different sources of information. Journal of Voice. doi:10.1016/j.jvoice.2022.12.005
NLM
Cardoso L da R, Zenari MS, Aguiar PM, Nemr K. Medications adverse effects on voice: comparison between different sources of information [Internet]. Journal of Voice. 2022 ;[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.jvoice.2022.12.005
Vancouver
Cardoso L da R, Zenari MS, Aguiar PM, Nemr K. Medications adverse effects on voice: comparison between different sources of information [Internet]. Journal of Voice. 2022 ;[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.jvoice.2022.12.005
Artigo de periodico
Brazilian regulation of biosimilar products: what is important to know (2022)
Oliveira, Sílvia Helena Cestari de; Alegria, Marcos Castanheira; Stephano, Marco Antônio
Source: BioPharm International. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Sílvia Helena Cestari de e ALEGRIA, Marcos Castanheira e STEPHANO, Marco Antônio. Brazilian regulation of biosimilar products: what is important to know. BioPharm International, v. 35, n. 9, p. 30–37, 2022Tradução . . Disponível em: https://www.biopharminternational.com/view/brazilian-regulation-of-biosimilar-products-what-is-important-to-know. Acesso em: 15 out. 2024.
APA
Oliveira, S. H. C. de, Alegria, M. C., & Stephano, M. A. (2022). Brazilian regulation of biosimilar products: what is important to know. BioPharm International, 35( 9), 30–37. Recuperado de https://www.biopharminternational.com/view/brazilian-regulation-of-biosimilar-products-what-is-important-to-know
NLM
Oliveira SHC de, Alegria MC, Stephano MA. Brazilian regulation of biosimilar products: what is important to know [Internet]. BioPharm International. 2022 ; 35( 9): 30–37.[citado 2024 out. 15 ] Available from: https://www.biopharminternational.com/view/brazilian-regulation-of-biosimilar-products-what-is-important-to-know
Vancouver
Oliveira SHC de, Alegria MC, Stephano MA. Brazilian regulation of biosimilar products: what is important to know [Internet]. BioPharm International. 2022 ; 35( 9): 30–37.[citado 2024 out. 15 ] Available from: https://www.biopharminternational.com/view/brazilian-regulation-of-biosimilar-products-what-is-important-to-know
Artigo de periodico
Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions (2022)
Silva, Daniela Amaral ; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 15 out. 2024.
APA
Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
NLM
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 out. 15 ] Available from: https://doi.org/10.14227/DT290222P62
Vancouver
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 out. 15 ] Available from: https://doi.org/10.14227/DT290222P62
Artigo de periodico
Conformity assessment of medicines containing antibiotics – a multivariate assessment (2022)
Lombardo, Márcia ; Silva, Cintia Margueiro da; Lourenço, Felipe Rebello
Source: Regulatory Toxicology and Pharmacology. Unidade: FCF
Subjects: MEDICAMENTO, ANTIBIÓTICOS, CONTROLE DA QUALIDADE, MEDIÇÃO DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOMBARDO, Márcia e SILVA, Cintia Margueiro da e LOURENÇO, Felipe Rebello. Conformity assessment of medicines containing antibiotics – a multivariate assessment. Regulatory Toxicology and Pharmacology, v. 136, p. 1-10 art. 105279, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.yrtph.2022.105279. Acesso em: 15 out. 2024.
APA
Lombardo, M., Silva, C. M. da, & Lourenço, F. R. (2022). Conformity assessment of medicines containing antibiotics – a multivariate assessment. Regulatory Toxicology and Pharmacology, 136, 1-10 art. 105279. doi:10.1016/j.yrtph.2022.105279
NLM
Lombardo M, Silva CM da, Lourenço FR. Conformity assessment of medicines containing antibiotics – a multivariate assessment [Internet]. Regulatory Toxicology and Pharmacology. 2022 ; 136 1-10 art. 105279.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.yrtph.2022.105279
Vancouver
Lombardo M, Silva CM da, Lourenço FR. Conformity assessment of medicines containing antibiotics – a multivariate assessment [Internet]. Regulatory Toxicology and Pharmacology. 2022 ; 136 1-10 art. 105279.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.yrtph.2022.105279
Artigo de periodico
Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection (2021)
Reyes, Roberto Rosales ; Esposito, Fernanda Ribeiro dos Santos ; Fontana, Herrison Yoshiki Yocida ; Fernández, José Luis Lezana; Lascurain, Ricardo ; Cruz, Miguel Ángel De la ; Araújo, Bruna Fuga; Lincopan, Nilton ; Preciado, José Ignacio Santos
Source: Diagnostic Microbiology and Infectious Disease. Unidades: ICB, FCF
Subjects: MICROBIOLOGIA, PSEUDOMONAS, FIBROSE CÍSTICA, RESISTÊNCIA MICROBIANA ÀS DROGAS, ANTIBIÓTICOS, CLONAGEM, VIRULÊNCIA, BACTÉRIAS AERÓBICAS GRAM-NEGATIVAS, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, MEDICAMENTO, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REYES, Roberto Rosales et al. Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection. Diagnostic Microbiology and Infectious Disease, v. 101, n. 1, p. 1-3, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.diagmicrobio.2021.115454. Acesso em: 15 out. 2024.
APA
Reyes, R. R., Esposito, F. R. dos S., Fontana, H. Y. Y., Fernández, J. L. L., Lascurain, R., Cruz, M. Á. D. la, et al. (2021). Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection. Diagnostic Microbiology and Infectious Disease, 101( 1), 1-3. doi:10.1016/j.diagmicrobio.2021.115454
NLM
Reyes RR, Esposito FR dos S, Fontana HYY, Fernández JLL, Lascurain R, Cruz MÁD la, Araújo BF, Lincopan N, Preciado JIS. Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection [Internet]. Diagnostic Microbiology and Infectious Disease. 2021 ; 101( 1): 1-3.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.diagmicrobio.2021.115454
Vancouver
Reyes RR, Esposito FR dos S, Fontana HYY, Fernández JLL, Lascurain R, Cruz MÁD la, Araújo BF, Lincopan N, Preciado JIS. Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection [Internet]. Diagnostic Microbiology and Infectious Disease. 2021 ; 101( 1): 1-3.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.diagmicrobio.2021.115454
Artigo de periodico
Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaCTX-M-15 infecting a critically endangered franciscana dolphin (Pontoporia blainvillei), Brazil (2021)
Fuentes-Castillo, Danny ; Sellera, Fábio Parra ; Goldberg, Daphne Wrobel; Fontana, Herrison ; Esposito, Fernanda Ribeiro dos Santos ; Cardoso, Brenda ; Ikeda, Joana; Kyllar, Anneliese; Catão-Dias, José Luiz ; Lincopan, Nilton
Source: Transboundary and Emerging Diseases. Unidades: FMVZ, ICB, FCF
Subjects: ENTEROBACTER, MAMÍFEROS MARINHOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, GENÉTICA BACTERIANA, MICROBIOLOGIA, ANTIBIÓTICOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUENTES-CASTILLO, Danny et al. Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaCTX-M-15 infecting a critically endangered franciscana dolphin (Pontoporia blainvillei), Brazil. Transboundary and Emerging Diseases, v. 68, n. 6, p. 3048-3054, 2021Tradução . . Disponível em: https://doi.org/10.1111/tbed.13980. Acesso em: 15 out. 2024.
APA
Fuentes-Castillo, D., Sellera, F. P., Goldberg, D. W., Fontana, H., Esposito, F. R. dos S., Cardoso, B., et al. (2021). Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaCTX-M-15 infecting a critically endangered franciscana dolphin (Pontoporia blainvillei), Brazil. Transboundary and Emerging Diseases, 68( 6), 3048-3054. doi:10.1111/tbed.13980
NLM
Fuentes-Castillo D, Sellera FP, Goldberg DW, Fontana H, Esposito FR dos S, Cardoso B, Ikeda J, Kyllar A, Catão-Dias JL, Lincopan N. Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaCTX-M-15 infecting a critically endangered franciscana dolphin (Pontoporia blainvillei), Brazil [Internet]. Transboundary and Emerging Diseases. 2021 ; 68( 6): 3048-3054.[citado 2024 out. 15 ] Available from: https://doi.org/10.1111/tbed.13980
Vancouver
Fuentes-Castillo D, Sellera FP, Goldberg DW, Fontana H, Esposito FR dos S, Cardoso B, Ikeda J, Kyllar A, Catão-Dias JL, Lincopan N. Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaCTX-M-15 infecting a critically endangered franciscana dolphin (Pontoporia blainvillei), Brazil [Internet]. Transboundary and Emerging Diseases. 2021 ; 68( 6): 3048-3054.[citado 2024 out. 15 ] Available from: https://doi.org/10.1111/tbed.13980
Artigo de periodico
Conformity decisions based on measurement uncertainty—a case study applied to agar diffusion microbiological assay (2020)
Separovic, Luciana; Bertanha, Maria Luiza de Godoy; Saviano, Alessandro Morais; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical Innovation. Unidade: FCF
Subjects: MEDIÇÃO DE RISCO, MEDICAMENTO, MÉTODO DE MONTE CARLO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEPAROVIC, Luciana et al. Conformity decisions based on measurement uncertainty—a case study applied to agar diffusion microbiological assay. Journal of Pharmaceutical Innovation, v. 15, p. 110-115, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12247-019-09374-8. Acesso em: 15 out. 2024.
APA
Separovic, L., Bertanha, M. L. de G., Saviano, A. M., & Lourenço, F. R. (2020). Conformity decisions based on measurement uncertainty—a case study applied to agar diffusion microbiological assay. Journal of Pharmaceutical Innovation, 15, 110-115. doi:10.1007/s12247-019-09374-8
NLM
Separovic L, Bertanha ML de G, Saviano AM, Lourenço FR. Conformity decisions based on measurement uncertainty—a case study applied to agar diffusion microbiological assay [Internet]. Journal of Pharmaceutical Innovation. 2020 ; 15 110-115.[citado 2024 out. 15 ] Available from: https://doi.org/10.1007/s12247-019-09374-8
Vancouver
Separovic L, Bertanha ML de G, Saviano AM, Lourenço FR. Conformity decisions based on measurement uncertainty—a case study applied to agar diffusion microbiological assay [Internet]. Journal of Pharmaceutical Innovation. 2020 ; 15 110-115.[citado 2024 out. 15 ] Available from: https://doi.org/10.1007/s12247-019-09374-8
Artigo de periodico
Perspectives about self-immolative drug delivery systems (2020)
Gonzaga, Rodrigo Vieira ; Nascimento, Lucas Adriano do; Santos, Soraya da Silva; Sanches, Bruna Machado Araújo; Giarolla, Jeanine ; Ferreira, Elizabeth Igne
Source: Journal of Pharmaceutical Sciences. Unidades: IQ, FCF
Subjects: LIGANTES, MEDICAMENTO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZAGA, Rodrigo Vieira et al. Perspectives about self-immolative drug delivery systems. Journal of Pharmaceutical Sciences, v. 109, p. 3262-3281, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2020.08.014. Acesso em: 15 out. 2024.
APA
Gonzaga, R. V., Nascimento, L. A. do, Santos, S. da S., Sanches, B. M. A., Giarolla, J., & Ferreira, E. I. (2020). Perspectives about self-immolative drug delivery systems. Journal of Pharmaceutical Sciences, 109, 3262-3281. doi:10.1016/j.xphs.2020.08.014
NLM
Gonzaga RV, Nascimento LA do, Santos S da S, Sanches BMA, Giarolla J, Ferreira EI. Perspectives about self-immolative drug delivery systems [Internet]. Journal of Pharmaceutical Sciences. 2020 ; 109 3262-3281.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.xphs.2020.08.014
Vancouver
Gonzaga RV, Nascimento LA do, Santos S da S, Sanches BMA, Giarolla J, Ferreira EI. Perspectives about self-immolative drug delivery systems [Internet]. Journal of Pharmaceutical Sciences. 2020 ; 109 3262-3281.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.xphs.2020.08.014
Artigo de periodico
Liquisolid pellets and liqui-pellets are not different (2020)
Pezzini, Bianca Ramos; Beringhs, André O'Reilly ; Ferraz, Humberto Gomes ; Silva, Marcos Antonio Segatto; Stulzer, Hellen Karine; Sonaglio, Diva
Source: AAPS PharmSciTech. Unidade: FCF
Subjects: PELETIZAÇÃO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZZINI, Bianca Ramos et al. Liquisolid pellets and liqui-pellets are not different. AAPS PharmSciTech, v. 21, p. 1-4 art. 72, 2020Tradução . . Disponível em: https://doi.org/10.1208/s12249-019-1590-x. Acesso em: 15 out. 2024.
APA
Pezzini, B. R., Beringhs, A. O. 'R., Ferraz, H. G., Silva, M. A. S., Stulzer, H. K., & Sonaglio, D. (2020). Liquisolid pellets and liqui-pellets are not different. AAPS PharmSciTech, 21, 1-4 art. 72. doi:10.1208/s12249-019-1590-x
NLM
Pezzini BR, Beringhs AO'R, Ferraz HG, Silva MAS, Stulzer HK, Sonaglio D. Liquisolid pellets and liqui-pellets are not different [Internet]. AAPS PharmSciTech. 2020 ; 21 1-4 art. 72.[citado 2024 out. 15 ] Available from: https://doi.org/10.1208/s12249-019-1590-x
Vancouver
Pezzini BR, Beringhs AO'R, Ferraz HG, Silva MAS, Stulzer HK, Sonaglio D. Liquisolid pellets and liqui-pellets are not different [Internet]. AAPS PharmSciTech. 2020 ; 21 1-4 art. 72.[citado 2024 out. 15 ] Available from: https://doi.org/10.1208/s12249-019-1590-x
Artigo de periodico-carta/editorial
Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" (2020)
Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo ; Storpirtis, Silvia
Source: Research in Social and Administrative Pharmacy. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Tácio de Mendonça e AGUIAR, Patrícia Melo e STORPIRTIS, Silvia. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients". Research in Social and Administrative Pharmacy. New York: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.sapharm.2019.12.017. Acesso em: 15 out. 2024. , 2020
APA
Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2020). Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients". Research in Social and Administrative Pharmacy. New York: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1016/j.sapharm.2019.12.017
NLM
Lima T de M, Aguiar PM, Storpirtis S. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" [Internet]. Research in Social and Administrative Pharmacy. 2020 ; 16( 3): 434-435.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.sapharm.2019.12.017
Vancouver
Lima T de M, Aguiar PM, Storpirtis S. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" [Internet]. Research in Social and Administrative Pharmacy. 2020 ; 16( 3): 434-435.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.sapharm.2019.12.017
Artigo de periodico
Development and validation of key performance indicators for medication management services provided for outpatients (2019)
Lima, Tácio de Mendonça ; Aguiar, Patricia Melo ; Storpirtis, Silvia
Source: Research in Social and Administrative Pharmacy. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Tácio de Mendonça e AGUIAR, Patricia Melo e STORPIRTIS, Silvia. Development and validation of key performance indicators for medication management services provided for outpatients. Research in Social and Administrative Pharmacy, v. 15, n. 9, p. 1080-1087, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2018.09.010. Acesso em: 15 out. 2024.
APA
Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2019). Development and validation of key performance indicators for medication management services provided for outpatients. Research in Social and Administrative Pharmacy, 15( 9), 1080-1087. doi:10.1016/j.sapharm.2018.09.010
NLM
Lima T de M, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients [Internet]. Research in Social and Administrative Pharmacy. 2019 ; 15( 9): 1080-1087.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.sapharm.2018.09.010
Vancouver
Lima T de M, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients [Internet]. Research in Social and Administrative Pharmacy. 2019 ; 15( 9): 1080-1087.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.sapharm.2018.09.010
Artigo de periodico
Preclinical investigation of methylene blue‐mediated antimicrobial photodynamic therapy on Leishmania parasites using real‐time bioluminescence (2019)
Cabral, Fernanda Viana ; Sabino, Caetano Pardial; Dimmer, Jesica Ayelen; Sauter, Ismael Pretto ; Cortez, Mauro ; Ribeiro, Martha Simões
Source: Photochemistry and Photobiology. Unidades: ICB, FCF
Subjects: PARASITOLOGIA, LEISHMANIOSE CUTÂNEA, RESISTÊNCIA MICROBIANA ÀS DROGAS, INFLAMAÇÃO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CABRAL, Fernanda Viana et al. Preclinical investigation of methylene blue‐mediated antimicrobial photodynamic therapy on Leishmania parasites using real‐time bioluminescence. Photochemistry and Photobiology, p. 7 , 2019Tradução . . Disponível em: https://doi.org/10.1111/php.13188. Acesso em: 15 out. 2024.
APA
Cabral, F. V., Sabino, C. P., Dimmer, J. A., Sauter, I. P., Cortez, M., & Ribeiro, M. S. (2019). Preclinical investigation of methylene blue‐mediated antimicrobial photodynamic therapy on Leishmania parasites using real‐time bioluminescence. Photochemistry and Photobiology, 7 . doi:10.1111/php.13188
NLM
Cabral FV, Sabino CP, Dimmer JA, Sauter IP, Cortez M, Ribeiro MS. Preclinical investigation of methylene blue‐mediated antimicrobial photodynamic therapy on Leishmania parasites using real‐time bioluminescence [Internet]. Photochemistry and Photobiology. 2019 ;7 .[citado 2024 out. 15 ] Available from: https://doi.org/10.1111/php.13188
Vancouver
Cabral FV, Sabino CP, Dimmer JA, Sauter IP, Cortez M, Ribeiro MS. Preclinical investigation of methylene blue‐mediated antimicrobial photodynamic therapy on Leishmania parasites using real‐time bioluminescence [Internet]. Photochemistry and Photobiology. 2019 ;7 .[citado 2024 out. 15 ] Available from: https://doi.org/10.1111/php.13188

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration